Planegg (pta/08.05.2018/07:30) Medigene AG (MDG1, Frankfurt, Prime Standard), announced that researchers from Max-Delbrück-Center for Molecular Medicine (MDC) and Charité, both in Berlin
Questionable members with clear conflict of interests meant that the monitoring committee failed to step in when Malpani Multispeciality Hospital in Jaipur tested Glenmark’s drug on 28 people without their consent.
A victim told News18 that the company had paid Rs 500 per person in exchange for participating in the illegal drug trial.
They make a guest appearance in at least half of the articles on Medical News Today. They are responsible for many of the biggest breakthroughs in medicine,
Bayer HealthCare and Regeneron Pharmaceuticals, Inc. announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the Phase 3